Woman looking into microscope
Join IDM Researchers

The Department of Infectious Diseases and Microbiology (IDM) is committed to training the next generation of scientists and public health professionals to enhance the control of infectious diseases in the human population.

Why Study IDM?

News

IDM assistant professor Toan Ha

Vietnam HIV stigma project offers lessons for the U.S.

Despite significant progress in HIV prevention and treatment, infections are rising among key populations, including men who have sex with men (MSM), and stigma in health care settings remains a major barrier to prevention, treatment and care. A new project led by researchers at the University of Pittsburgh School of Public Health aims to address this challenge through a culturally tailored intervention in Vietnam that could offer a scalable model for reducing HIV stigma globally.

IDM staff person Erin Schuetz

Staff awards: Schuetz’s work in community a tribute to her father

“It’s been part of my life since childhood,” says IDM's Erin Schuetz, who earned a Chancellor’s Distinguished Service Award for Staff in community engagement. She credits her father, Fred, who served on numerous boards, as an early influence. “My dad was what I call a quiet leader. When something needed to be done, he would just be there. People say, ‘Someone should do something,’ and he would remind me, ‘You are someone, and you can do something.’”

Assistant Professor of Infectious Diseases and Microbiology, Jeremy Martinson

Pitt Public Health faculty study hepatitis B–liver cancer connection

Liver cancer is the sixth most commonly diagnosed cancer globally, primarily occurring as hepatocellular carcinoma (HCC). In sub-Saharan Africa and other developing regions, chronic hepatitis B virus (HBV) infection persists as a critical public health challenge and a primary driver of HCC cases. To improve HBV drug targets and predict disease severity, researchers at the University of Pittsburgh School of Public Health’s Department of Infectious Diseases and Microbiology, led by Jeremy Martinson, PhD, collaborated with an international team to examine region-specific genetic factors influencing HBV progression.